Dense Red Blood Cells in Sickle Cell Children (DREPADENSE)
Quantitative and Prognostic Evaluation of Dense Red Blood Cells in Sickle Cell Children: Single-center Study From the Creteil (France) Pediatric Cohort
研究概览
地位
条件
详细说明
An association between red blood cell density and hemolytic parameters, and clinical manifestations has been demonstrated in adults with sickle cell anemia.
This factor has not been studied in children. The identification of predictive biomarkers of disease severity, especially of specific pediatric complications (cerebral vasculopathy, splenic sequestration, Dactylitis) would be useful for optimal care of the children and early intensification Red blood cell density might be one of these prognostic factors.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
-
Créteil、法国、94000
- Chi Creteil
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Age: 18 months-18 years
- Patient with sickle cell disease namely SS, or S / Beta0 or S / Beta +
- Patient regularly followed in the pediatric cohort of the CHI Creteil
- Patient Hospitalized for an annual check-up
- With or without intensification by Hydroxycarbamide
- patient who haven't been transfused within 3 months
- Whose parents have given their informed consent
- Patients insured to the French social scheme
Exclusion Criteria:
- Sickle cell SC disease
- Having received an allogeneic bone marrow transplantation
- Under regular transfusion program
- Having received a transfusion within 3 months
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Common arm
Children with sickle cell anemia will be included.
Blood samples of all the included patients will be collected during a day-hospitalization for a planned chek-up.
For all these patients the number of dense erythrocytes will be evaluated
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
number of dense red blood cells (DRBC)
大体时间:1 day
|
Evaluation of the number of dense red blood cells in the blood of affected children
|
1 day
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
biological profile
大体时间:1 day
|
hemolytic parameters (LDH, bilirubin, Hemoglobin level)
|
1 day
|
|
Number of patients with velocities > 200 cm/sec on transcranial doppler
大体时间:1 day
|
Cerebral vasculopathy (correlation with patients with abnormal velocities on transcranial doppler (TCD)(> 200 cm/sec) History of dactylitis History of ischemic lesions on magnetic resonance imaging (MRI) |
1 day
|
|
Number of patients with history of acute splenic sequestration,
大体时间:1 day
|
1 day
|
|
|
Number of patients with history of acute chest syndrome
大体时间:1 day
|
1 day
|
|
|
Number of patients with History of dactylitis
大体时间:1 day
|
1 day
|
|
|
Number of patients with history of abnormal transcranial doppler (TCD) (≥ 200 cm/sec)
大体时间:1 day
|
1 day
|
|
|
Number of patients with history of ischemic lesions on magnetic resonance imaging (MRI)
大体时间:1 day
|
1 day
|
|
|
Number of patients with hydroxycarbamide treatment
大体时间:1 day
|
effect of hydroxycarbamide on the % DRBC
|
1 day
|
|
Number of dense red blood cells
大体时间:1 day
|
number of dense red blood cells in the pediatric population with no known blood condition
|
1 day
|
合作者和调查者
调查人员
- 首席研究员:Corinne Pondarre, MD PhD、Chi Creteil
出版物和有用的链接
一般刊物
- Bartolucci P, Brugnara C, Teixeira-Pinto A, Pissard S, Moradkhani K, Jouault H, Galacteros F. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifestations and hemolysis. Blood. 2012 Oct 11;120(15):3136-41. doi: 10.1182/blood-2012-04-424184. Epub 2012 Aug 23. Erratum In: Blood. 2014 Mar 20;123(12):1972.
- Yawn BP, Buchanan GR, Afenyi-Annan AN, Ballas SK, Hassell KL, James AH, Jordan L, Lanzkron SM, Lottenberg R, Savage WJ, Tanabe PJ, Ware RE, Murad MH, Goldsmith JC, Ortiz E, Fulwood R, Horton A, John-Sowah J. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517. Erratum In: JAMA. 2014 Nov 12;312(18):1932. JAMA. 2015 Feb 17;313(7):729.
- Quinn CT, Shull EP, Ahmad N, Lee NJ, Rogers ZR, Buchanan GR. Prognostic significance of early vaso-occlusive complications in children with sickle cell anemia. Blood. 2007 Jan 1;109(1):40-5. doi: 10.1182/blood-2006-02-005082. Epub 2006 Aug 29.
- Miller ST, Sleeper LA, Pegelow CH, Enos LE, Wang WC, Weiner SJ, Wethers DL, Smith J, Kinney TR. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000 Jan 13;342(2):83-9. doi: 10.1056/NEJM200001133420203.
- Benkerrou M, Alberti C, Couque N, Haouari Z, Ba A, Missud F, Boizeau P, Holvoet L, Ithier G, Elion J, Baruchel A, Ducrocq R. Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study. Br J Haematol. 2013 Dec;163(5):646-54. doi: 10.1111/bjh.12590. Epub 2013 Oct 10.
- Bernaudin F, Verlhac S, Arnaud C, Kamdem A, Chevret S, Hau I, Coic L, Leveille E, Lemarchand E, Lesprit E, Abadie I, Medejel N, Madhi F, Lemerle S, Biscardi S, Bardakdjian J, Galacteros F, Torres M, Kuentz M, Ferry C, Socie G, Reinert P, Delacourt C. Impact of early transcranial Doppler screening and intensive therapy on cerebral vasculopathy outcome in a newborn sickle cell anemia cohort. Blood. 2011 Jan 27;117(4):1130-40; quiz 1436. doi: 10.1182/blood-2010-06-293514. Epub 2010 Nov 10.
- Thornburg CD, Files BA, Luo Z, Miller ST, Kalpatthi R, Iyer R, Seaman P, Lebensburger J, Alvarez O, Thompson B, Ware RE, Wang WC; BABY HUG Investigators. Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood. 2012 Nov 22;120(22):4304-10; quiz 4448. doi: 10.1182/blood-2012-03-419879. Epub 2012 Aug 22. Erratum In: Blood. 2016 Dec 15;128(24):2869.
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.